Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis | Zendy

Chinwe C. Madubata | Zendy; Margaret A. Olsen | Zendy; Dustin Stwalley | Zendy; David H. Gutmann | Zendy; Kimberly Johnson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis

Author(s) -

Chinwe C. Madubata,

Margaret A. Olsen,

Dustin Stwalley,

David H. Gutmann,

Kimberly Johnson

Publication year - 2014

Publication title -

genetics in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.509

H-Index - 128

eISSN - 1530-0366

pISSN - 1098-3600

DOI - 10.1038/gim.2014.70

Subject(s) - odds ratio , neurofibromatosis , confidence interval , medicine , pediatrics , pathology

Neurofibromatosis type 1 has been linked to several neurological conditions, including epilepsy, Parkinson disease, headache, multiple sclerosis, and sleep disturbances, predominantly through case reports and patient series that lack comparison groups. Our objective was to assess whether specific neurological conditions occur more frequently in individuals with neurofibromatosis type 1 versus those without neurofibromatosis type 1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research